Literature DB >> 12634353

American genotype structures decrease dengue virus output from human monocytes and dendritic cells.

Raymond Cologna1, Rebeca Rico-Hesse.   

Abstract

The dengue virus type 2 structures probably involved in human virulence were previously defined by sequencing the complete genome of both American and Southeast (SE) Asian genotype templates in patient serum (K. C. Leitmeyer et al., J. Virol. 73:4738-4747, 1999). We have now evaluated the effects of introducing a mutation in the envelope glycoprotein (E) gene and/or replacement of 5'- and 3'-nontranslated regions on dengue virus replication in human primary cell cultures. A series of chimeric infectious clones were generated containing different combinations of American and SE Asian genotype sequences. Some of the chimeric viruses had altered plaque morphology in mammalian cells; however, they replicated at similar rates in mosquito cells as measured by quantitative reverse transcription-PCR and plaque assay. Although susceptibility to virus infection varied from donor to donor in experiments using human macrophage and dendritic cells, we were able to measure consistent differences in viral RNA output per infected cell. Using this measurement, we demonstrated that the chimeric virus containing the E mutation had a lower virus output compared to the parental infectious clone. A larger reduction in virus output was observed for the triple mutant and the wild-type, American genotype virus from which chimeric inserts were derived. It appears that the three changes function synergistically, although the E mutation alone gives a lower output compared to the 5'- and 3'-terminal mutations. The data suggest that these changes may be responsible for decreased dengue virus replication in human target cells and for virulence characteristics during infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12634353      PMCID: PMC150669          DOI: 10.1128/jvi.77.7.3929-3938.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  A live attenuated recombinant dengue-4 virus vaccine candidate with restricted capacity for dissemination in mosquitoes and lack of transmission from vaccinees to mosquitoes.

Authors:  J M Troyer; K A Hanley; S S Whitehead; D Strickman; R A Karron; A P Durbin; B R Murphy
Journal:  Am J Trop Med Hyg       Date:  2001-11       Impact factor: 2.345

2.  Replication of dengue virus type 2 in human monocyte-derived macrophages: comparisons of isolates and recombinant viruses with substitutions at amino acid 390 in the envelope glycoprotein.

Authors:  M J Pryor; J M Carr; H Hocking; A D Davidson; P Li; P J Wright
Journal:  Am J Trop Med Hyg       Date:  2001-11       Impact factor: 2.345

3.  Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections.

Authors:  Daniel H Libraty; Timothy P Endy; Huo-Shu H Houng; Sharone Green; Siripen Kalayanarooj; Saroj Suntayakorn; Wanya Chansiriwongs; David W Vaughn; Ananda Nisalak; Francis A Ennis; Alan L Rothman
Journal:  J Infect Dis       Date:  2002-04-16       Impact factor: 5.226

4.  Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua.

Authors:  E Harris; E Videa; L Pérez; E Sandoval; Y Téllez; M L Pérez; R Cuadra; J Rocha; W Idiaquez; R E Alonso; M A Delgado; L A Campo; F Acevedo; A Gonzalez; J J Amador; A Balmaseda
Journal:  Am J Trop Med Hyg       Date:  2000 Jul-Aug       Impact factor: 2.345

5.  Increased production of interleukin-8 in primary human monocytes and in human epithelial and endothelial cell lines after dengue virus challenge.

Authors:  Irene Bosch; Kris Xhaja; Luis Estevez; Gregory Raines; Heather Melichar; Rajas V Warke; Marcia V Fournier; Francis A Ennis; Alan L Rothman
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

6.  Plasma concentrations of sVCAM-1 and severity of dengue infections.

Authors:  B Murgue; O Cassar; X Deparis
Journal:  J Med Virol       Date:  2001-09       Impact factor: 2.327

7.  Activation of terminally differentiated human monocytes/macrophages by dengue virus: productive infection, hierarchical production of innate cytokines and chemokines, and the synergistic effect of lipopolysaccharide.

Authors:  Yun-Chi Chen; Sheng-Yuan Wang
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

8.  High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever.

Authors:  Daniel H Libraty; Paul R Young; Darren Pickering; Timothy P Endy; Siripen Kalayanarooj; Sharone Green; David W Vaughn; Ananda Nisalak; Francis A Ennis; Alan L Rothman
Journal:  J Infect Dis       Date:  2002-09-16       Impact factor: 5.226

9.  Coagulation abnormalities in dengue hemorrhagic Fever: serial investigations in 167 Vietnamese children with Dengue shock syndrome.

Authors:  Bridget A Wills; Emmanuelle E Oragui; Alick C Stephens; Olufunmilayo A Daramola; Nguyen Minh Dung; Ha Thi Loan; Nguyen Vinh Chau; Mary Chambers; Kasia Stepniewska; Jeremy J Farrar; Michael Levin
Journal:  Clin Infect Dis       Date:  2002-07-11       Impact factor: 9.079

10.  Hantavirus infection of dendritic cells.

Authors:  Martin J Raftery; Annette A Kraus; Rainer Ulrich; Detlev H Krüger; Günther Schönrich
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

View more
  69 in total

Review 1.  Dengue: defining protective versus pathologic immunity.

Authors:  Alan L Rothman
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

2.  Homology of complete genome sequences for dengue virus type-1, from dengue-fever- and dengue-haemorrhagic-fever-associated epidemics in Hawaii and French Polynesia.

Authors:  A Imrie; C Roche; Z Zhao; S Bennett; M Laille; P Effler; V-M Cao-Lormeau
Journal:  Ann Trop Med Parasitol       Date:  2010-04

3.  Aedes aegypti vectorial capacity is determined by the infecting genotype of dengue virus.

Authors:  Justin R Anderson; Rebeca Rico-Hesse
Journal:  Am J Trop Med Hyg       Date:  2006-11       Impact factor: 2.345

Review 4.  Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis.

Authors:  Karen Clyde; Jennifer L Kyle; Eva Harris
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

5.  Selection for virulent dengue viruses occurs in humans and mosquitoes.

Authors:  Raymond Cologna; Philip M Armstrong; Rebeca Rico-Hesse
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 6.  RNA virus genomics: a world of possibilities.

Authors:  Edward C Holmes
Journal:  J Clin Invest       Date:  2009-09       Impact factor: 14.808

7.  Clade replacements in dengue virus serotypes 1 and 3 are associated with changing serotype prevalence.

Authors:  Chunlin Zhang; Mammen P Mammen; Piyawan Chinnawirotpisan; Chonticha Klungthong; Prinyada Rodpradit; Patama Monkongdee; Suchitra Nimmannitya; Siripen Kalayanarooj; Edward C Holmes
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

8.  Sylvatic dengue viruses share the pathogenic potential of urban/endemic dengue viruses.

Authors:  Nikos Vasilakis; Jane Cardosa; Mawlouth Diallo; Amadou A Sall; Edward C Holmes; Kathryn A Hanley; Scott C Weaver; Javier Mota; Rebeca Rico-Hesse
Journal:  J Virol       Date:  2010-04       Impact factor: 5.103

9.  Variation in inflammatory/regulatory cytokines in secondary, tertiary, and quaternary challenges with dengue virus.

Authors:  Beatriz Sierra; Ana B Pérez; Mayling Alvarez; Gissel García; Katrin Vogt; Eglys Aguirre; Kathrin Schmolke; Hans-Dieter Volk; María G Guzmán
Journal:  Am J Trop Med Hyg       Date:  2012-07-16       Impact factor: 2.345

10.  Dengue virus evolution and virulence models.

Authors:  Rebeca Rico-Hesse
Journal:  Clin Infect Dis       Date:  2007-04-18       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.